Breaking News Instant updates and real-time market news.

CYTR

CytRx

$0.54

-0.0273 (-4.82%)

09:02
10/10/16
10/10
09:02
10/10/16
09:02

CytRx reports interim results from Phase 1b/2 trial of aldoxorubicin

CytRx presented results from its on-going Phase 1b/2 trial of aldoxorubicin in combination with ifosfamide/mesna in patients with advanced sarcomas at the European Society for Medical Oncology 2016 Congress being held in Copenhagen, Denmark. Of the 36 evaluable patients receiving either 170mg/m2 or 250mg/m2 of aldoxorubicin plus ifosfamide and mesna, 13 of 36 (36%) achieved a partial response of the target lesion by RECIST 1.1 criteria, 22 of 36 (61%) had stable disease, and one patient had progressive disease. Median progression-free survival has not been reached, and dose-limiting toxicities were not observed in either cohort. No clinically significant cardiac toxicities were seen. The most common Grade 3 or 4 adverse events were neutropenia (71%), anemia (54%), thrombocytopenia (17%) and febrile neutropenia (14%). There were nine treatment-related serious adverse events, and no treatment-related deaths. The trial has been expanded to allow continued enrollment of additional sarcoma patients at the 250 mg/m2 dose of aldoxorubicin with ifosfamide and mesna.

CYTR CytRx
$0.54

-0.0273 (-4.82%)

01/07/16
JEFF
01/07/16
INITIATION
Target $3
JEFF
Hold
CytRx initiated with a Hold at Jefferies
Jefferies analyst Chris Howerton started CytRx with a Hold rating and $3 price target. The stock is fairly valued given the opportunity for Aldoxorubicin in 2nd-line soft tissue sarcoma, the analyst tells investors in a research note.
01/07/16
01/07/16
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Agilent (A) initiated with a Hold at Deutsche Bank... Alexion (ALXN) initiated with a Buy at SunTrust... Alibaba (BABA) initiated with an Outperform at Baird... Bruker (BRKR) initiated with a Market Perform at Avondale... Care Capital Properties (CCP) initiated with a Neutral at Mizuho... Celgene (CELG) initiated with a Buy at SunTrust... Cepheid (CPHD) initiated with an Outperform at Avondale... Community Bank System (CBU) initiated with a Neutral at Piper Jaffray... CytRx (CYTR) initiated with a Hold at Jefferies... Del Taco (TACO) initiated with a Buy (yesterday) at BTIG... Depomed (DEPO) initiated with a Neutral at Mizuho... Ensco (ESV) initiated with an Equal Weight at Stephens... FCB Financial (FCB) initiated with a Buy at Gabelli... FactSet (FDS) initiated with a Hold at Evercore ISI... Fluidigm (FLDM) initiated with a Buy at Deutsche Bank... GTT Communications (GTT) initiated with an Overweight at Stephens... IBERIABANK (IBKC) initiated with a Neutral at Piper Jaffray... Illumina (ILMN) initiated with a Hold at Deutsche Bank... InspireMD (NSPR) initiated with a Buy at Rodman & Renshaw... Johnson Controls (JCI) initiated with an Outperform at Oppenheimer... McGraw Hill Financial (MHFI) initiated with a Buy at Evercore ISI... Moody's (MCO) initiated with a Hold at Evercore ISI... Myriad Genetics (MYGN) initiated with a Buy at Deutsche Bank... NBT Bancorp (NBTB) initiated with a Neutral at Piper Jaffray... Omnicell (OMCL) initiated with a Buy at Benchmark... Ophthotech (OPHT) initiated with a Buy at SunTrust... Paycom (PAYC) initiated with an Outperform at Baird... Paylocity (PCTY) initiated with an Outperform at Baird... PerkinElmer (PKI) initiated with a Hold at Deutsche Bank... Rowan Companies (RDC) initiated with an Equal Weight at Stephens... Shopify (SHOP) initiated with an Outperform at Baird... Syngenta (SYT) initiated with a Neutral at Macquarie... Thermo Fisher (TMO) initiated with a Buy at Deutsche Bank... Trovagene (TROV) initiated with a Market Perform at Avondale... UTi Worldwide (UTIW) to host special shareholder meeting... Waters (WAT) initiated with a Hold at Deutsche Bank... Wayfair (W) initiated with a Neutral at Baird... Willis Towers Watson (WLTW) initiated with an Underweight at JPMorgan.
07/12/16
07/12/16
NO CHANGE
Target $3

Outperform
CytRx price target lowered to $3 from $8 at FBR Capital
FBR Capital analyst Christopher James cut his price target for CytRx to $3 after the company's Phase III study with aldoxorubicin in patients with relapsed or refractory soft-tissue sarcoma was unable to meet its primary endpoint. Despite missing on the endpoint, aldoxorubicin demonstrated clear clinical activity, with an objective response rate nearly double the rate observed within the comparator arm, James tells investors in a research note. He keeps an Outperform rating on CytRx. In pre-market trading, the stock is down 69% to 77c.
07/12/16
JEFF
07/12/16
NO CHANGE
Target $0.75
JEFF
Hold
CytRx price target lowered to 75c from $2.50 at Jefferies
Jefferies analyst Chris Howerton cut his price target for CytRx to 75c from $2.50 after removing aldoxorubicin from his model following today's study failure. The analyst does not see a path forward for the drug in soft tissue sarcomas or any other indications. He keeps a Hold rating on the name. FBR Capital analyst Christopher James said this morning that despite missing on the endpoint, aldoxorubicin demonstrated clear clinical activity, with an objective response rate nearly double the rate observed within the comparator arm. CytRx is down 62% to 95c in late morning trading.

TODAY'S FREE FLY STORIES

GE

General Electric

$16.24

-0.535 (-3.19%)

10:35
01/19/18
01/19
10:35
01/19/18
10:35
Hot Stocks
Former GE vice chairman Wright says major issue is liabilities on balance sheet »

Speaking in a CNBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

10:35
01/19/18
01/19
10:35
01/19/18
10:35
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

NINE

Nine Energy Services

10:31
01/19/18
01/19
10:31
01/19/18
10:31
Syndicate
Breaking Syndicate news story on Nine Energy Services »

Nine Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

10:30
01/19/18
01/19
10:30
01/19/18
10:30
General news
U.S. January consumer confidence slid 1.5 points to 94.4 »

U.S. January consumer…

PAYC

Paycom

$89.86

0.74 (0.83%)

, ALRM

Alarm.com

$39.43

1.16 (3.03%)

10:29
01/19/18
01/19
10:29
01/19/18
10:29
Conference/Events
Jefferies software analyst holds an analyst/industry conference call »

Software Analyst DiFucci…

PAYC

Paycom

$89.86

0.74 (0.83%)

ALRM

Alarm.com

$39.43

1.16 (3.03%)

CA

CA Technologies

$34.19

-0.28 (-0.81%)

RHT

Red Hat

$125.41

-0.06 (-0.05%)

ORCL

Oracle

$50.43

0.2 (0.40%)

SSNC

SS&C

$49.94

0.23 (0.46%)

VMW

VMware

$136.19

0.56 (0.41%)

CTXS

Citrix

$91.38

0.19 (0.21%)

MSFT

Microsoft

$90.10

-0.04 (-0.04%)

SYMC

Symantec

$27.25

-0.27 (-0.98%)

PANW

Palo Alto Networks

$157.60

-0.22 (-0.14%)

APTI

Apptio

$24.23

0.23 (0.96%)

CHKP

Check Point

$103.20

-0.37 (-0.36%)

NICE

Nice

$93.83

1.2 (1.30%)

SPLK

Splunk

$91.43

0.86 (0.95%)

RNG

RingCentral

$53.55

0.35 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 30

    Jan

  • 31

    Jan

  • 31

    Jan

  • 31

    Jan

  • 31

    Jan

  • 05

    Feb

  • 06

    Feb

  • 06

    Feb

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 12

    Feb

  • 26

    Feb

  • 27

    Feb

10:25
01/19/18
01/19
10:25
01/19/18
10:25
General news
The Michigan sentiment drop to a 6-month low of 94.4 »

The Michigan sentiment…

URG

UR-Energy

$0.72

-0.0279 (-3.72%)

10:25
01/19/18
01/19
10:25
01/19/18
10:25
Conference/Events
UR-Energy to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

10:25
01/19/18
01/19
10:25
01/19/18
10:25
Conference/Events
Leerink healthcare analysts hold an analyst/industry conference call »

Healthcare Analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 01

    Feb

  • 18

    Mar

BDX

Becton Dickinson

$233.54

1.42 (0.61%)

, ATHN

athenahealth

$125.53

-0.65 (-0.52%)

10:24
01/19/18
01/19
10:24
01/19/18
10:24
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

BDX

Becton Dickinson

$233.54

1.42 (0.61%)

ATHN

athenahealth

$125.53

-0.65 (-0.52%)

CRBP

Corbus Pharmaceuticals

$7.95

-0.25 (-3.05%)

TTD

Trade Desk

$48.36

-1.12 (-2.26%)

IPCI

Intellipharmaceutics

$0.80

-0.02 (-2.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 02

    Feb

  • 06

    Feb

Z

Zillow

$43.97

-0.57 (-1.28%)

, ZG

Zillow

$43.86

-0.49 (-1.10%)

10:24
01/19/18
01/19
10:24
01/19/18
10:24
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

Z

Zillow

$43.97

-0.57 (-1.28%)

ZG

Zillow

$43.86

-0.49 (-1.10%)

BLMN

Bloomin' Brands

$21.96

0.02 (0.09%)

PH

Parker-Hannifin

$210.94

0.4 (0.19%)

MKC

McCormick

$100.10

-2.81 (-2.73%)

WNS

WNS Holdings

$44.30

-0.98 (-2.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 26

    Feb

NKE

Nike

$66.12

2.0086 (3.13%)

, ANF

Abercrombie & Fitch

$19.45

0.5 (2.64%)

10:24
01/19/18
01/19
10:24
01/19/18
10:24
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

NKE

Nike

$66.12

2.0086 (3.13%)

ANF

Abercrombie & Fitch

$19.45

0.5 (2.64%)

CMG

Chipotle

$338.74

1.21 (0.36%)

FL

Foot Locker

$49.49

0.8999 (1.85%)

PM

Philip Morris

$107.12

2.05 (1.95%)

MO

Altria Group

$71.38

1.35 (1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 01

    Feb

  • 06

    Feb

ADT

ADT Inc.

, APO

Apollo Global

$34.07

-1.005 (-2.87%)

10:22
01/19/18
01/19
10:22
01/19/18
10:22
Syndicate
Breaking Syndicate news story on ADT Inc., Apollo Global »

ADT Inc. opens at $12.65,…

ADT

ADT Inc.

APO

Apollo Global

$34.07

-1.005 (-2.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 19

    Jan

NSPR

InspireMD

$0.17

-0.0019 (-1.11%)

10:21
01/19/18
01/19
10:21
01/19/18
10:21
Hot Stocks
InspireMD reports independent publication highlighting advantages of CGuard EPS »

InspireMD announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ODP

Office Depot

$3.51

0.01 (0.29%)

10:20
01/19/18
01/19
10:20
01/19/18
10:20
Options
Defensive option play in Office Depot »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:20
01/19/18
01/19
10:20
01/19/18
10:20
General news
Treasury Action: yields paused at highs after surging »

Treasury Action: yields…

10:18
01/19/18
01/19
10:18
01/19/18
10:18
Conference/Events
RBC Capital technology analysts hold an analyst/industry conference call »

Technology Analysts…

$NSD

NASDAQ Market Internals

10:17
01/19/18
01/19
10:17
01/19/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
01/19/18
01/19
10:16
01/19/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
01/19/18
01/19
10:15
01/19/18
10:15
General news
FX Action: The dollar »

FX Action: The dollar…

FAZ

Direxion Financial Bear 3x

$10.45

-0.1438 (-1.36%)

10:10
01/19/18
01/19
10:10
01/19/18
10:10
Options
Direxion Daily Financial Bear 3X Shares draws a notable option block »

Direxion Daily Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NINE

Nine Energy Services

10:09
01/19/18
01/19
10:09
01/19/18
10:09
Syndicate
Breaking Syndicate news story on Nine Energy Services »

Nine Energy Services IPO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

COLD

Americold Realty Trust

10:09
01/19/18
01/19
10:09
01/19/18
10:09
Syndicate
Breaking Syndicate news story on Americold Realty Trust »

Americold Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

QRVO

Qorvo

$68.76

-1.92 (-2.72%)

10:05
01/19/18
01/19
10:05
01/19/18
10:05
Technical Analysis
Technical Take: Qorvo drops, levels to watch »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:04
01/19/18
01/19
10:04
01/19/18
10:04
General news
Potential government shutdown not doing much to rattle market »

Stock futures were a bit…

ADT

ADT Inc.

, APO

Apollo Global

$34.37

-0.7 (-2.00%)

10:03
01/19/18
01/19
10:03
01/19/18
10:03
Syndicate
ADT Inc. IPO indicated to open at $12.75-$13.00 on 5M shares »

ADT Inc. priced 105M…

ADT

ADT Inc.

APO

Apollo Global

$34.37

-0.7 (-2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 19

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.